Arizona’s Bioscience Roadmap to 2030

A new plan for Arizona’s growing bioscience ecosystem outlines how the state can build on over two decades of progress and become a national leader in the field.

The latest version of Arizona’s Bioscience Roadmap, launching the week of September 8, 2025, uses arizona’s skilled workers, strong research, and entrepreneurial spirit to boost the economy and improve the health and well-being of Arizonans.

The report looks at Arizona’s strengths and weaknesses, and acknowledges potential challenges with federal funding for bioscience research.

More than 140,000 people work in bioscience companies and hospitals in Arizona. These jobs pay, on average, 30% more than other private-sector jobs in the state. The Roadmap suggests that opportunities to work with semiconductor manufacturing and other tech industries could lead to growth over the next five years.

Arizona is especially strong in areas like medical device manufacturing, neuroscience, oncology, and precision medicine.

“With the right vision, strategies, determination, and courage – and with its rapidly growing resources, existing and potential strengths, and remarkable collaborative spirit – Arizona has a chance to make transformational contributions to bioscientific research and clinical care, with a profound impact on people here in Arizona and around the world,” said Dr. Eric Reiman, chair of the Flinn Foundation board of directors.

“The Flinn Foundation is excited to help with this effort.”

The Bioscience Roadmap is the longest-running statewide bioscience plan in the country. The Flinn Foundation started it in 2002. Since then, the Foundation has tracked and shared data on the six main parts of Arizona’s bioscience industry:

• Agricultural feedstock and industrial biosciences.
• Bioscience-related distribution.
• Medical devices and